TGFB1 and diabetes mellitus: Observed results about prevention of experimental streptozotocin-diabetes only in DP pretreated groups, may suggest that purine compounds, uric acid and some volatile toxic compounds may suppress oral tolerance, probably via IL-6 and TGF-β cytokine interaction.